Síndrome de lisis tumoral

Revista Clinica Espanola

Volumn 196, Issue 5, 1996, Pages 310-312

  Barreiro, G ^a   Gainza F J ^b   Canovas A ^a   Alonso, J J ^a   Onate J ^a   Irurzun, J ^a   Alvarez A ^a   Aguirre, C ^a  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; TUMOR LYSIS SYNDROME;

COMBINED MODALITY THERAPY; HUMANS; RISK FACTORS; TUMOR LYSIS SYNDROME;

EID: 4243099355     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Arrambide K, Toto RD. Tumor lysis syndrome Semin Nephrol 1993: 13.273-280.
2. Bedrna J, Polcak J Akuter harnleiterverschluss nach bestrahlung chronischer leukamien mit rontgenstrahlen. Med Kin 1929: 25 1.700-1.701.
3. Cohen LF, Balow JE, Magrath IT, Poplack DG, Ziegler JL. Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med 1980: 68-486-491
4. Tsokos GC, Balow JE, Spiegel RJ, Magrath IT. Renal and metabolic complication of undifferenciated and lymphoblastic lymphomas. Medicine 1981; 60: 218-229
5. Boles J, Dutel JL, Briere J. et al Acute renal failure caused by extreme hyperphosphatemia after chemoterapy of an acute lymphoblastic leukemia. Cancer 1984, 53:2.425-2.429.
6. Jasek AM, Day HJ Acute spontaneous tumor lysis syndrome. Am J Hematol 1994; 47:129-131.
7. Heney D, Essex-Cater A, Brocklebanck C, Bailey C, Lewis IJ. Continuos arteriovenous haemofiltration in the treatment of tumour lisis syndrome Pediatr Nephrol 1990; 4:245-247.
8. Murphy SB, Bowman WP, Abromowith M. et al. Results of treatment of advanced stage Burkitt's lymphoma and B cell (Slg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986: 12 1.732-1.739.
9. Boccia RV, Longo DL, Lieber MI, et al. Multiple recurrences of acute tumor lysis syndrome in an indolent non-Hogdkin's lymphoma. Cancer 1985; 56:2 295-2.297
10. Silverman P, Distelhorst CW. Metabolic emergencies in clinical oncoloy. Semin Oncol 1989; 16:504-505.
11. Bernacer M, Aracil J, Contra T, et al. Sindrome de lisis tumoral aguda (SLTA) durante el tratamiento de inducción en el linfoma de Burkitt: estudio de 16 pacientes An Esp Pediatr 1988. 29 (suppl 34P):109-112.
12. García ML, Feliu J, Vicente J, Garrido P. Sindrome de lisis tumoral en la enfermedad de Hogdkin refractana. Sangre 1988, 33:56.
13. Hande KR, Garrow GC. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma Am J Med 1993: 94 133-139.
14. Dombret H, Hunault M, Faucher C, Dombret MC, Degos L. Acute lyssis pneumopathy after chemoterapy for acute myelomonocytic leukemia with abnormal marrow eosinophils. Cancer 1992, 69.1.356-1 361
15. Przepiorka D, Gonzales-Chambers R. Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crsis: role of high-dose Ara-C Bone Marrow Transplant 1990: 6-281-282.
16. List AF, Kummet TD, Adams JD, Chung HG. Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate. Am J Med 1990; 89:388-390.
17. Nomdedeu J, Martine R, Sureda A. et al. Acute tumor lysis syndrome complicating conditioning therapy for bone marrow transplantation in a patient with chronic lymphocytic leukemia. Bone Marrow Transplant 1994: 13:659-660
18. Barton JC. Tumor lysis syndrome in nonhematopietic neoplasms. Cancer 1989; 64 738-740
19. Vogelzang NJ, Nehmark RA, Nath KA. Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma JAMA 1983, 249 513-514.
20. Stark ME, Dyer MC, Coonley CJ. Fatal acute tumor lysis syndrome with metastasic breast carcinoma. Cancer 1987: 60-762-764.
21. Tomlinson GC, Solberg LA Jr. Acute tumor lysis syndrome with metastatic medulloblastoma. A case report Cancer 1984; 53:1.783-1 785
22. Dirix LY, Prove A. Becquart D, Wouters E. Vermeulen P. Van Oosterom A. Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma Cancer 1991; 67:2.207-2.210
23. Shamseddine Al, Khalil AM, Wehbeh MH. Acute tumor lysis syndrome with squamous cell carcinoma of the vulva. Gynecol Oncol 1993; 51.258-260.
24. Khan J, Broadbent VA. Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma. Pediatr Hematol Oncol 1993; 10.151-155.
25. Bilgrami SF, Fallon BG Tumor lysis syndrome after combination chemotherapy for ovarian cancer. Med Pediatr Oncol 1993; 21:521-524.
26. Dhingra K, Newcom SR. Acute tumor lysis syndrome in non-Hegkin lymphoma induced by dexametasona. Am J Hematol 1988; 29:115-116.
27. Simmons ED, Somberg KA. Acute tumor lysis syndrome after intrathecal methotrexate administration Cancer 1991; 67:2 062-2 065
28. Cech P, Block JB, Cone LA. et al. Tumor lysis syndrome after tamoxifen flare. N Eng J Med 1986; 315:263-264.
29. Fer MF, Bottino GC, Sherwin SA, et al Atypical tumor lysis syndrome in a patient with T cell lymphoma treated with recombinant leukocite interferon. Am J Med 1984, 77:953-956.
30. Fleming DR, Henslee-Downey PJ, Coffey CW. Radiation induced acute tumor lysis syndrome in the bone marrow transplant setting. Bone Marrow Transplant 1991; 8.235-236.
31. Schilsky RL. Renal and metabolic toxicities of cancer chemotherapy Semin Oncol 1982; 9:75-83.
32. Stapleton FB, Strother DR, Roy III S. et al. Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic leukemia. Pediatrics 1988, 82:863-869
33. Arseneau JC, Bagley CM, Anderson T, Canellos GP, Hyperkaliemia. a sequel to chemoterapy of Burkitt's lymphoma. Lancet 1973; 1:10.
34. Dumlay RW, Camp MA, Allon M, Calcitriol in prolonged hypocalcemia due to the tumor lysis syndrome. Ann Intern Med 1989: 110 162-164
35. Klinenberg JR, Kippen I, Bluestone R. Hyperuricemic nephropathy. pathophysiologic features and factors influencing urate deposition. Nephron 1975, 14 88-98
36. DeConti R, Calabresi P. Use of allopurinol for prevention and control of hyperuncemia in patients with neoplastic disease. N Engl J Med 1966; 274:481-486.
37. Krakoff IH, Meyer RL. Prevention of hyperuncemia in leukemia and lymphoma. Use of allopurinol, a xanthne oxidase inhibitor JAMA 1965: 193: 89-94.
38. Hande KR, Hixson CV, Chabner BA. Postcnemotherapy purine excretion in lymphoma patients receiving allopurinol. Cancer Res 1981; 41:2-273-2.279.
39. Band PR, Silverberg DS, Henderson JF. et al. Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. N Engl J Med 1970; 7:354-357.
40. Elion GV, Benezra FM, Beardmore TD. et al. Studies with allopurinol in patients with impaired renal function Adv Exp Med Biol 1980; 122:263-267.
41. Sakarcan A. Quigley R Hyperphosphatemia in tumor lysis syndrome. the role of hemodialysis and continuous veno-venous hemofiltration. Pediatr Nephrol 1994. 8:351-353